Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen on Tuesday reported fourth-quarter revenue and profit that shrank from a year ago, as… Read More »Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies